Skip to content

Effects of Bloodletting Acupuncture for Subacute and Chronic Non-specific Low Back Pain

Effects of Bloodletting Acupuncture for Subacute and Chronic Non-specific Low Back Pain - a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06190366
Enrollment
108
Registered
2024-01-05
Start date
2023-12-19
Completion date
2025-12-31
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Low

Brief summary

Evaluation of a bloodletting acupuncture at the fossa poplitea in comparison to bloodletting acupuncture at the regio glutaea and a waiting list control group in patients with subacute and chronic non-specific pain low back pain.

Interventions

PROCEDUREBloodletting acupuncture at the fossa poplitea

This group is treated with bloodletting acupuncture at the fossa poplitea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.

PROCEDUREBloodletting acupuncture at the regio glutaea

This group is treated with bloodletting acupuncture at the regio glutaea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Specialist confirmed diagnosis of subacute or chronic non-specific low back pain for at least 6 weeks prior to inclusion * Average pain intensity with at least 50 mm on the VAS from 0 to 100 mm

Exclusion criteria

* Serious illnesses * Poor general condition * Coagulation disorder, therapy with anticoagulants * Thrombophlebitis, skin inflammation in the area of the lower extremities * Alcohol, drug or medication addiction * Pregnancy * Lack of willingness to cooperate, linguistically or mentally unable to understand the contents of the study * Participation in another clinical trial during the study period * Starting a new therapy for the treatment of low back pain in the last 2 weeks

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in average pain intensity in previous weekBaseline, 3 weeksIntensity of pain in previous week as measured on a 100 mm visual analog scale (0-100).

Secondary

MeasureTime frameDescription
Change from baseline in pain bothersomeness in previous weekBaseline, 3 weeks, 6 weeksBothersomeness in previous week as measured on a 100 mm visual analog scale (0-100).
Change from baseline for pain self-efficacyBaseline, 3 weeks, 6 weeksUse of standardized Pain Self-Efficacy Questionnaire (PSEQ). The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Change from baseline for anxiety and depressionBaseline, 3 weeks, 6 weeksUse of standardized Hospital Anxiety and Depression Scale (HADS). The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Change from baseline for work productivityBaseline, 3 weeks, 6 weeksUse standardized Work Productivity and Activity Impairment Questionnaire (WPAI) to assess employment status and productivity. The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Change from baseline in average pain intensity in previous weekBaseline, 6 weeksIntensity of pain in previous week as measured on a 100 mm visual analog scale (0-100).
Change from baseline in average pain intensity of the last 24 hoursBaseline, 3 weeks, 6 weeksIntensity of pain in previous week as measured on a 100 mm visual analog scale (0-100).
Change from baseline for back pain specific disabilityBaseline, 3 weeks, 6 weeksUse of standardized Roland Morris Disability Questionnaire (RMDQ) to assess back pain specific disability. The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.
Change from baseline for days with pain medication useBaseline, 3 weeks, 6 weeksSpecific self-reported pain medication use
Change from baseline for health related quality of lifeBaseline, 3 weeks, 6 weeksUse of standardized Short Form 36 Health Survey (SF-36). The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.

Other

MeasureTime frameDescription
Treatment expectation: effectiveness of bloodletting acupuncture in reducing low back painBaselineAssess treatment expectation at baseline, Likert scale (1-very good effectiveness to 5-poor effectiveness)
Number of participants with adverse events as a measure of safety and treatment adherence3 weeks, 6 weeksIdentify and assess self reported and unanticipated adverse events over the course of the study as a measure of safety and treatment adherence.
Treatment adherence3 weeksAssess treatment adherence according to attendance during 3 week intervention period.

Countries

Germany

Contacts

Primary ContactMiriam Rösner
naturheilkunde.studien@immanuel.de+49 30 80505 682

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026